Comparison results
Add for comparison more than one drug or diagnosis.
Results: Differences General | ✘Ovarian androblastoma | |||||||||
Related research | Analogs | |||||||||
| ||||||||||
Distinctive symptoms | ||||||||||
Register, to see more distinctive signs of diseases and studies | 84% | |||||||||
Register, to see more distinctive signs of diseases and studies | 53% | |||||||||
clitoris | 47% | |||||||||
uterine appendages are increase | 45% | |||||||||
hirsutism | 45% | |||||||||
appendages of the uterus | 45% | |||||||||
emaciation | 44% | |||||||||
rapid weight loss | 44% | |||||||||
female pelvic organs | 41% | |||||||||
lack of menstruation | 41% | |||||||||
hair loss on the crown | 40% | |||||||||
vaginal discharge | 39% | |||||||||
ovarian tumors | 39% | |||||||||
monthly gas scanty | 39% | |||||||||
bloody discharge from the vagina | 37% | |||||||||
stopped menstruation | 36% | |||||||||
pimples on the face | 35% | |||||||||
acne | 34% | |||||||||
virile syndrome | 34% | |||||||||
receding hairline | 34% | |||||||||
acne face | 33% | |||||||||
rough voice | 33% | |||||||||
ovarian apoplexy | 32% | |||||||||
oncology | 31% | |||||||||
menstruation disorder | 31% | |||||||||
hypertrophy of the uterine body | 31% | |||||||||
rashes on the face | 31% | |||||||||
clitoromegaly | 31% | |||||||||
involution of the mammary glands | 30% | |||||||||
pimples on the body | 30% | |||||||||
excess testesterone | 28% | |||||||||
monthly short | 28% | |||||||||
rare menstruation | 27% | |||||||||
vaginal discharge in girls | 27% | |||||||||
premature menstruation | 27% | |||||||||
rupture of the uterus | 27% | |||||||||
altered voice | 26% | |||||||||
appendages of pain | 26% | |||||||||
additional mammary gland | 26% | |||||||||
testesterone deficiency | 26% | |||||||||
premature sexual development | 25% | |||||||||
removal of the uterine body | 25% | |||||||||
rashes on the genitals | 25% | |||||||||
baldness | 24% | |||||||||
change in appetite | 24% | |||||||||
cancer | 24% | |||||||||
to increase the mammary glands | 24% | |||||||||
postmenopause | 24% | |||||||||
fat deposits | 23% | |||||||||
solid tumors | 23% | |||||||||
indecision | 22% | |||||||||
rash on the body | 22% | |||||||||
apoplexy | 22% | |||||||||
voice disorders | 22% | |||||||||
hair loss | 22% | |||||||||
menopause | 22% | |||||||||
skin problems | 22% | |||||||||
genital neoplasms | 21% | |||||||||
weight change | 20% | |||||||||
myocardial infarction | 20% | |||||||||
general weakness | 19% | |||||||||
radiation therapy | 19% | |||||||||
no appetite | 19% | |||||||||
muscle pain | 19% | |||||||||
does not tolerate pain | 19% | |||||||||
aching | 18% | |||||||||
radiation damage | 18% | |||||||||
feeling of heat | 17% | |||||||||
necrosis | 17% | |||||||||
high temperature | 17% | |||||||||
consequences of surgery | 17% | |||||||||
there are no complaints | 16% |
Instructions
Video

|